drugset
drugset / Trial / NCT01118572

A Study to Verify the Efficacy of YM177 (Celecoxib) in Postoperative Pain Patients

NCT01118572 ↗

Phase 3 Completed 616 enrolled Astellas Pharma Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Aim of the study is to compare efficacy and safety of YM177 with placebo and etodolac in patients with postoperative pain.

Timeline

Start
2010-02
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified — Oral
Comparator Etodolac Unknown — Oral

Indications

No indication recorded.